Joseph Papa

Joseph Papa

Chief Executive Officer at EMERGENT BIOSOLUTIONS INC.

Net worth: 37 M $ as of 2024-02-28

68 year
Health Technology
Consumer Services
Distribution Services

Profile

Joseph C.
Papa
is an American businessperson who founded Bionanosim (BNS) Ltd.
and who has been at the helm of 17 different companies.
Mr. Papa occupies the position of Independent Chairman of SparingVision SAS, Chairman for Beyeonics Surgical Ltd., President & Chief Executive Officer at Emergent BioSolutions, Inc., Executive Advisor at Water Street Healthcare Partners LLC and President at Sergeant's Pet Care Products, Inc. Joseph C.
Papa
is also on the board of Candel Therapeutics, Inc. In his past career Mr. Papa occupied the position of Director at Bausch Health Cos., Inc. Chairman & Chief Executive Officer for Bausch & Lomb, Inc. Chief Executive Officer & Director at Bausch + Lomb Corp.
and Chief Executive Officer of Bausch & Lomb Holdings, Inc. (which are all subsidiaries of Bausch Health Cos., Inc.), Chairman, President & Chief Executive Officer for Perrigo Co. Plc Chairman, President & Chief Executive Officer for Perrigo Co. and President of Perrigo Florida, Inc. (Florida) (both are subsidiaries of Perrigo Co. Plc), Chairman & Chief Executive Officer at Bionanosim (BNS) Ltd., Chairman, CEO-Pharmaceutical & Technologies at Cardinal Health, Inc., Principal at Novartis AG and Vice President-Marketing for Novartis International AG (a subsidiary of Novartis AG), President & Chief Operating Officer at Actavis, Inc., President of Actavis, Inc., President & Chief Operating Officer of DuPont Pharmaceuticals Co., President for G.D.
Searle & Co., Inc., President & Chief Operating Officer of Actavis Pharma, Inc. and President-North American Global Country Operations at Pharmacia Corp.
He received an undergraduate degree from the University of Connecticut and an MBA from Kellogg School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-03-16 3,072,039 ( 0.84% ) 29 M $ 2024-02-28
2023-02-23 472,222 ( 0.13% ) 8 M $ 2024-02-28
2023-06-27 38,032 ( 0.13% ) 70 740 $ 2024-02-28

Joseph Papa active positions

CompaniesPositionStart
CANDEL THERAPEUTICS, INC. Director/Board Member 2022-08-07
EMERGENT BIOSOLUTIONS INC. Chief Executive Officer 2024-02-20
Chairman 2023-10-03
Consultant / Advisor 2023-05-31
Chairman 2023-04-04
President -
All active positions of Joseph Papa

Former positions of Joseph Papa

CompaniesPositionEnd
PROMETHEUS BIOSCIENCES, INC. Director/Board Member 2023-06-15
BAUSCH + LOMB CORPORATION Chief Executive Officer 2023-03-03
BAUSCH HEALTH COMPANIES INC. Chief Executive Officer 2022-05-09
░░░░░ ░░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Joseph Papa's experience

Training of Joseph Papa

University of Connecticut Undergraduate Degree
Kellogg School of Management Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joseph Papa's experience

Connections

100 +

1st degree connections

28

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies8
CARDINAL HEALTH, INC.

Distribution Services

SMITH & NEPHEW PLC

Health Technology

NOVARTIS AG

Health Technology

EMERGENT BIOSOLUTIONS INC.

Health Technology

BAUSCH HEALTH COMPANIES INC.

Health Technology

CANDEL THERAPEUTICS, INC.

Commercial Services

PERRIGO COMPANY PLC

Health Technology

BAUSCH + LOMB CORPORATION

Health Technology

Private companies18

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Process Industries

Consumer Non-Durables

Health Technology

Health Technology

Retail Trade

The University of Connecticut Foundation, Inc.

Miscellaneous

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

See company connections
  1. Stock
  2. Insiders
  3. Joseph Papa